| WKY |
glomerular capillary ultrafiltration coefficient |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
days
| 9 |
0.04 |
nl/(s x mmHg) |
0.0 |
0.01 |
inulin analysis by liquid phase colorimetry |
glomerular capillary |
0.0 |
PA IV 50mg/kg |
|
|
kf |
100590 |
2479 |
| WKY |
glomerular filtration rate |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
days
| 5 |
1.24 |
ml/min |
0.07 |
0.16 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
|
|
|
100598 |
2479 |
| WKY |
single nephron glomerular filtration rate |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
days
| 5 |
67.0 |
nl/min |
13.0 |
29.07 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
|
|
sngfr |
100608 |
2479 |
| WKY |
glomerular capillary ultrafiltration coefficient |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
days
| 5 |
0.06 |
nl/(s x mmHg) |
0.02 |
0.04 |
inulin analysis by liquid phase colorimetry |
glomerular capillary |
0.0 |
PA IV 50mg/kg |
|
|
kf |
100616 |
2479 |
| WKY |
single nephron glomerular filtration rate |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
days
| 6 |
17.0 |
nl/min |
2.0 |
4.9 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
15 |
days |
sngfr |
100518 |
2479 |
| WKY |
single nephron glomerular filtration rate |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
days
| 9 |
50.0 |
nl/min |
3.0 |
9.0 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
|
|
sngfr |
100520 |
2479 |
| WKY |
single nephron glomerular filtration rate |
controlled enalapril content drinking water (50 mg/l) (for 7 days) then puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
days
| 8 |
61.0 |
nl/min |
3.0 |
8.49 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
|
|
|
100521 |
2479 |
| WKY |
afferent arteriolar plasma flow rate |
0.9% sodium chloride solution (3 ml) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
kidney plasma flow trait |
male |
days
| 8 |
191.0 |
nl/min |
16.0 |
45.25 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
|
|
|
afferent arteriolar plasma flow rate |
100529 |
2479 |
| WKY |
afferent arteriolar plasma flow rate |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
kidney plasma flow trait |
male |
days
| 9 |
169.0 |
nl/min |
14.0 |
42.0 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
|
|
afferent arteriolar plasma flow rate |
100530 |
2479 |
| WKY |
glomerular capillary hydraulic pressure |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood molecular composition trait |
male |
days
| 6 |
50.0 |
mmHg |
3.0 |
7.35 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
15 |
days |
pgc |
100533 |
2479 |
| WKY |
glomerular capillary hydraulic pressure |
0.9% sodium chloride solution (3 ml) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood molecular composition trait |
male |
days
| 8 |
47.0 |
mmHg |
2.0 |
5.66 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
|
|
|
pgc |
100534 |
2479 |
| WKY |
glomerular filtration rate to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
days
| 8 |
0.54 |
ml/min/100g |
0.02 |
0.05 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
99948 |
2378 |
| WKY |
renal filtration fraction |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
days
| 8 |
0.23 |
null |
0.14 |
0.4 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
99958 |
2378 |
| WKY |
glomerular filtration rate to body weight ratio |
unilateral nephrectomy (for 28 days) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
days
| 11 |
0.52 |
ml/min/100g |
0.01 |
0.04 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
99980 |
2378 |
| WKY |
glomerular filtration rate to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
days
| 17 |
0.69 |
ml/min/100g |
0.03 |
0.13 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
99982 |
2378 |
| WKY |
renal filtration fraction |
unilateral nephrectomy (for 28 days) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
days
| 11 |
0.23 |
null |
0.01 |
0.03 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
99985 |
2378 |
| WKY |
renal filtration fraction |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
days
| 16 |
0.22 |
null |
0.01 |
0.04 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
99988 |
2378 |
| WKY |
renal filtration fraction |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) and bosentan (100 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
days
| 16 |
0.21 |
null |
0.01 |
0.03 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
99989 |
2378 |
| WKY |
glomerular filtration rate |
0.9% sodium chloride solution (3 ml) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
days
| 8 |
1.34 |
ml/min |
0.06 |
0.17 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
|
|
|
|
100457 |
2479 |
| WKY |
glomerular filtration rate |
controlled enalapril content drinking water (50 mg/l) (for 497 days) then puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
days
| 9 |
1.43 |
ml/min |
0.09 |
0.27 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
490 |
days |
|
100462 |
2479 |
| WKY |
renal filtration fraction |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
days
| 17 |
0.21 |
null |
0.01 |
0.05 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
99987 |
2378 |
| WKY |
glomerular capillary ultrafiltration coefficient |
0.9% sodium chloride solution (3 ml) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
days
| 9 |
0.07 |
nl/(s x mmHg) |
0.01 |
0.04 |
inulin analysis by liquid phase colorimetry |
glomerular capillary |
0.0 |
|
|
|
kf |
100587 |
2479 |
| WKY |
glomerular filtration rate |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
days
| 5 |
1.22 |
ml/min |
0.03 |
0.07 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
|
|
|
100596 |
2479 |
| WKY |
single nephron glomerular filtration rate |
puromycin aminonucleoside (50 mg/kg) then 0.9% sodium chloride solution (for 0.5 hours) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
days
| 5 |
57.0 |
nl/min |
8.0 |
17.89 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
|
|
sngfr |
100611 |
2479 |
| WKY |
glomerular filtration rate |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
days
| 8 |
1.14 |
ml/min |
0.13 |
0.37 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
490 |
days |
|
100461 |
2479 |
| WKY |
glomerular capillary hydraulic pressure |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood molecular composition trait |
male |
days
| 9 |
68.0 |
mmHg |
2.0 |
6.0 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
|
|
pgc |
100535 |
2479 |
| WKY |
renal filtration fraction |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
days
| 8 |
0.26 |
null |
0.01 |
0.04 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
99956 |
2378 |
| WKY |
renal filtration fraction |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
days
| 8 |
0.23 |
null |
0.12 |
0.34 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
99957 |
2378 |
| WKY |
glomerular filtration rate to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) and bosentan (100 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
days
| 16 |
0.67 |
ml/min/100g |
0.02 |
0.08 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
99984 |
2378 |
| WKY |
renal filtration fraction |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
days
| 17 |
0.29 |
null |
0.01 |
0.05 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
99986 |
2378 |
| WKY |
glomerular capillary ultrafiltration coefficient |
controlled enalapril content drinking water (50 mg/l) (for 7 days) then puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
days
| 8 |
0.11 |
nl/(s x mmHg) |
0.03 |
0.07 |
inulin analysis by liquid phase colorimetry |
glomerular capillary |
0.0 |
PA IV 50mg/kg |
|
|
kf |
100591 |
2479 |
| WKY |
glomerular filtration rate |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
days
| 7 |
0.31 |
ml/min |
0.05 |
0.13 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
15 |
days |
|
100455 |
2479 |
| WKY |
glomerular filtration rate |
0.9% sodium chloride solution (3 ml) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
days
| 9 |
1.51 |
ml/min |
0.12 |
0.36 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
|
|
|
|
100460 |
2479 |
| WKY |
glomerular filtration rate |
controlled enalapril content drinking water (50 mg/l) (for 7 days) then puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
days
| 8 |
1.25 |
ml/min |
0.09 |
0.25 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
|
|
|
100459 |
2479 |
| WKY |
glomerular capillary hydraulic pressure |
0.9% sodium chloride solution (3 ml) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood molecular composition trait |
male |
days
| 9 |
49.0 |
mmHg |
1.0 |
3.0 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
|
|
|
pgc |
100532 |
2479 |
| WKY |
afferent arteriolar plasma flow rate |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
kidney plasma flow trait |
male |
days
| 6 |
186.0 |
nl/min |
17.0 |
41.64 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
15 |
days |
afferent arteriolar plasma flow rate |
100528 |
2479 |
| WKY |
renal filtration fraction |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) and bosentan (100 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
days
| 6 |
0.21 |
null |
0.01 |
0.03 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
99959 |
2378 |
| WKY |
glomerular filtration rate to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
days
| 16 |
0.66 |
ml/min/100g |
0.02 |
0.09 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
99983 |
2378 |
| WKY |
glomerular capillary ultrafiltration coefficient |
0.9% sodium chloride solution (3 ml) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
days
| 8 |
0.09 |
nl/(s x mmHg) |
0.01 |
0.03 |
inulin analysis by liquid phase colorimetry |
glomerular capillary |
0.0 |
|
|
|
kf |
100589 |
2479 |
| WKY |
glomerular filtration rate |
puromycin aminonucleoside (50 mg/kg) then saralasin (0.3 mg/kg/hr) (for 0.5 hours) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
days
| 5 |
1.49 |
ml/min |
0.09 |
0.2 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
|
|
|
100597 |
2479 |
| WKY |
single nephron glomerular filtration rate |
puromycin aminonucleoside (50 mg/kg) then saralasin (0.3 mg/kg/hr) (for 0.5 hours) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
days
| 5 |
82.0 |
nl/min |
10.0 |
22.36 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
|
|
sngfr |
100609 |
2479 |
| WKY |
glomerular capillary ultrafiltration coefficient |
puromycin aminonucleoside (50 mg/kg) then saralasin (0.3 mg/kg/hr) (for 0.5 hours) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
days
| 5 |
0.16 |
nl/(s x mmHg) |
0.05 |
0.1 |
inulin analysis by liquid phase colorimetry |
glomerular capillary |
0.0 |
PA IV 50mg/kg |
|
|
kf |
100617 |
2479 |
| WKY |
glomerular filtration rate |
controlled enalapril content drinking water (50 mg/l) (for 22 days) then puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
days
| 5 |
0.38 |
ml/min |
0.08 |
0.18 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
15 |
days |
|
100456 |
2479 |
| WKY |
glomerular filtration rate |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
days
| 9 |
1.28 |
ml/min |
0.06 |
0.18 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
|
|
|
100458 |
2479 |
| WKY |
afferent arteriolar plasma flow rate |
0.9% sodium chloride solution (3 ml) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
kidney plasma flow trait |
male |
days
| 9 |
165.0 |
nl/min |
17.0 |
51.0 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
|
|
|
afferent arteriolar plasma flow rate |
100527 |
2479 |
| WKY |
glomerular capillary hydraulic pressure |
controlled enalapril content drinking water (50 mg/l) (for 7 days) then puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood molecular composition trait |
male |
days
| 8 |
46.0 |
mmHg |
2.0 |
5.66 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
|
|
pgc |
100536 |
2479 |
| WKY |
glomerular filtration rate to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
days
| 8 |
0.79 |
ml/min/100g |
0.03 |
0.08 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
99946 |
2378 |
| WKY |
glomerular filtration rate to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
days
| 8 |
0.52 |
ml/min/100g |
0.03 |
0.07 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
99947 |
2378 |
| WKY |
glomerular capillary ultrafiltration coefficient |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
days
| 6 |
0.02 |
nl/(s x mmHg) |
0.0 |
0.01 |
inulin analysis by liquid phase colorimetry |
glomerular capillary |
0.0 |
PA IV 50mg/kg |
15 |
days |
kf |
100588 |
2479 |
| WKY |
glomerular filtration rate |
puromycin aminonucleoside (50 mg/kg) then 0.9% sodium chloride solution (for 0.5 hours) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
days
| 5 |
1.19 |
ml/min |
0.08 |
0.18 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
|
|
|
100599 |
2479 |
| WKY |
single nephron glomerular filtration rate |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
days
| 5 |
65.0 |
nl/min |
9.0 |
20.12 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
|
|
sngfr |
100610 |
2479 |
| WKY |
afferent arteriolar plasma flow rate |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
kidney plasma flow trait |
male |
days
| 5 |
270.0 |
nl/min |
44.0 |
98.39 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
|
|
qa |
100612 |
2479 |
| WKY |
afferent arteriolar plasma flow rate |
puromycin aminonucleoside (50 mg/kg) (for 0.5 hours) then saralasin (0.3 mg/kg/hr) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
kidney plasma flow trait |
male |
days
| 5 |
314.0 |
nl/min |
34.0 |
76.03 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
|
|
qa |
100613 |
2479 |
| WKY |
glomerular filtration rate to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
days
| 17 |
0.5 |
ml/min/100g |
0.03 |
0.12 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
168 |
days |
|
99981 |
2378 |
| WKY |
glomerular filtration rate |
0.9% sodium chloride solution (3 ml) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
days
| 9 |
1.17 |
ml/min |
0.05 |
0.15 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
|
|
|
|
100454 |
2479 |
| WKY |
single nephron glomerular filtration rate |
0.9% sodium chloride solution (3 ml) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
days
| 9 |
44.4 |
nl/min |
4.0 |
12.0 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
|
|
|
sngfr |
100517 |
2479 |
| WKY |
single nephron glomerular filtration rate |
0.9% sodium chloride solution (3 ml) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
days
| 8 |
52.0 |
nl/min |
3.0 |
8.49 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
|
|
|
sngfr |
100519 |
2479 |
| WKY |
afferent arteriolar plasma flow rate |
controlled enalapril content drinking water (50 mg/l) (for 7 days) then puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
kidney plasma flow trait |
male |
days
| 8 |
244.0 |
nl/min |
21.0 |
59.4 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
|
|
afferent arteriolar plasma flow rate |
100531 |
2479 |
| WKY |
glomerular filtration rate to body weight ratio |
unilateral nephrectomy (for 28 days) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
days
| 7 |
0.49 |
ml/min/100g |
0.03 |
0.08 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
99945 |
2378 |
| WKY |
glomerular filtration rate to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) and bosentan (100 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
days
| 6 |
0.5 |
ml/min/100g |
0.02 |
0.06 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
99949 |
2378 |
| WKY |
renal filtration fraction |
unilateral nephrectomy (for 28 days) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
glomerular filtration trait |
male |
days
| 7 |
0.23 |
null |
0.01 |
0.03 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
28 |
days |
|
99955 |
2378 |